Literature DB >> 2755310

Quantification, characterization and fatty acid composition of lysophosphatidic acid in different rat tissues.

A K Das1, A K Hajra.   

Abstract

The amount and composition of lysophosphatidate present in different rat tissues have been estimated by an internal standard method in which a synthetic unnatural isomer (1-heptadecanoyl-rac-glycerol-3-phosphate) was added to the total lipid extracts, and the fatty acid composition of purified lysophosphatidate was determined. Lipids from tissues were extracted under acidic conditions, and the lysophosphatidate was purified by solvent partitions followed by thin-layer chromatography in multiple solvent systems. The purified lipid was shown to be 1-acyl-sn-glycerol-3-phosphate by chromatographic and chemical analysis, by its resistance to hydrolysis when treated with phospholipase A2 and also by its complete conversion to 1-acyl-sn-glycerol when treated with alkaline phosphatase. The fatty acid constituents of this lipid were determined by gas-liquid chromatography of the derived methyl esters. The concentrations (nmol/g of tissue) of lysophosphatidate in various tissues were: 86.2 +/- 4.2 in brain, 60.3 +/- 6.3 in liver, 46.4 +/- 6.5 in kidney, 30.6 +/- 5.0 in testis, 22.3 in heart and 19.3 in lung. Mostly (80%) saturated fatty acids were found to be present in this lyso lipid. A significantly high level of stearic acid was present in this lipid from all the tissues (50-60% in liver, kidney, brain and testis, and about 40% in heart and lung) compared to palmitic acid (10-15% in liver, kidney and brain and 25-30% in testis, heart and lung). The fatty acid compositions of phosphatidic acid, the putative product of lysophosphatidate acylation, from different tissues were also determined and palmitate was found to be the major saturated fatty acid.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2755310     DOI: 10.1007/BF02535172

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  24 in total

1.  IN VIVO CONVERSION OF LABELED FATTY ACIDS TO THE SPHINGOLIPID FATTY ACIDS IN RAT BRAIN.

Authors:  A K HAJRA; N S RADIN
Journal:  J Lipid Res       Date:  1963-10       Impact factor: 5.922

2.  DETERMINATION OF POLAR LIPIDS: QUANTITATIVE COLUMN AND THIN-LAYER CHROMATOGRAPHY.

Authors:  G ROUSER; G KRITCHEVSKY; C GALLI; D HELLER
Journal:  J Am Oil Chem Soc       Date:  1965-03       Impact factor: 1.849

3.  A reagent for the non-destructive location of steroids and some other lipophilic materials on silica gel thin-layer chromatograms.

Authors:  R S Wright
Journal:  J Chromatogr       Date:  1971-07-08

4.  Species variations in phospholipid class distribution of organs. II. Heart and skeletal muscle.

Authors:  G Simon; G Rouser
Journal:  Lipids       Date:  1969-11       Impact factor: 1.880

5.  Species variations in phospholipid class distribution of organs. I. Kidney, liver and spleen.

Authors:  G Rouser; G Simon; G Kritchevsky
Journal:  Lipids       Date:  1969-11       Impact factor: 1.880

6.  Phospholipase A2 activity specific for phosphatidic acid. A possible mechanism for the production of arachidonic acid in platelets.

Authors:  M M Billah; E G Lapetina; P Cuatrecasas
Journal:  J Biol Chem       Date:  1981-06-10       Impact factor: 5.157

7.  Cytidine diphosphate diglyceride of bovine brain. Positional distribution of fatty acids and analysis of major molecular species.

Authors:  W Thompson; G MacDonald
Journal:  Eur J Biochem       Date:  1976-05-17

Review 8.  Inositol trisphosphate, a novel second messenger in cellular signal transduction.

Authors:  M J Berridge; R F Irvine
Journal:  Nature       Date:  1984 Nov 22-28       Impact factor: 49.962

9.  Molecular species of mono-, di-, and triphosphoinositides of bovine brain.

Authors:  B J Holub; A Kuksis; W Thompson
Journal:  J Lipid Res       Date:  1970-11       Impact factor: 5.922

10.  The phosphatidylinositol cycle and the regulation of arachidonic acid production.

Authors:  E G Lapetina; M M Billah; P Cuatrecasas
Journal:  Nature       Date:  1981-07-23       Impact factor: 49.962

View more
  19 in total

1.  Diversity of lysophosphatidic acid receptor-mediated intracellular calcium signaling in early cortical neurogenesis.

Authors:  Adrienne E Dubin; Deron R Herr; Jerold Chun
Journal:  J Neurosci       Date:  2010-05-26       Impact factor: 6.167

Review 2.  Insights into the pharmacological relevance of lysophospholipid receptors.

Authors:  Tetsuji Mutoh; Richard Rivera; Jerold Chun
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

Review 3.  Lysophosphatidic acid (LPA) receptors: signaling properties and disease relevance.

Authors:  Mu-En Lin; Deron R Herr; Jerold Chun
Journal:  Prostaglandins Other Lipid Mediat       Date:  2009-03-04       Impact factor: 3.072

Review 4.  Volume-dependent osmolyte efflux from neural tissues: regulation by G-protein-coupled receptors.

Authors:  Stephen K Fisher; Tooba A Cheema; Daniel J Foster; Anne M Heacock
Journal:  J Neurochem       Date:  2008-06-02       Impact factor: 5.372

5.  Anatomical location of LPA1 activation and LPA phospholipid precursors in rodent and human brain.

Authors:  Estibaliz González de San Román; Iván Manuel; María Teresa Giralt; Jerold Chun; Guillermo Estivill-Torrús; Fernando Rodríguez de Fonseca; Luis Javier Santín; Isidro Ferrer; Rafael Rodríguez-Puertas
Journal:  J Neurochem       Date:  2015-04-27       Impact factor: 5.372

6.  Expression of lysophosphatidic acid receptor in rat astrocytes: mitogenic effect and expression of neurotrophic genes.

Authors:  S Tabuchi; K Kume; M Aihara; T Shimizu
Journal:  Neurochem Res       Date:  2000-05       Impact factor: 3.996

7.  Human platelets respond differentially to lysophosphatidic acids having a highly unsaturated fatty acyl group and alkyl ether-linked lysophosphatidic acids.

Authors:  Akira Tokumura; Junya Sinomiya; Seishi Kishimoto; Tamotsu Tanaka; Kentaro Kogure; Takayuki Sugiura; Kiyoshi Satouchi; Keizo Waku; Kenji Fukuzawa
Journal:  Biochem J       Date:  2002-08-01       Impact factor: 3.857

8.  Lysophospholipid receptors LPA1-3 are not required for the inhibitory effects of LPA on mouse retinal growth cones.

Authors:  Eric Birgbauer; Jerold Chun
Journal:  Eye Brain       Date:  2010

9.  Atypical Antipsychotic Exposure May Not Differentiate Metabolic Phenotypes of Patients with Schizophrenia.

Authors:  Kristen M Ward; Larisa Yeoman; Cora McHugh; A Zarina Kraal; Stephanie A Flowers; Amy E Rothberg; Alla Karnovsky; Arun K Das; Vicki L Ellingrod; Kathleen A Stringer
Journal:  Pharmacotherapy       Date:  2018-06       Impact factor: 4.705

Review 10.  Biological roles of lysophospholipid receptors revealed by genetic null mice: an update.

Authors:  Ji Woong Choi; Chang-Wook Lee; Jerold Chun
Journal:  Biochim Biophys Acta       Date:  2008-03-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.